capecitabine

You have access
Comparative Effectiveness of 5-Fluorouracil with and without Oxaliplatin in the Treatment of Colorectal Cancer in Clinical Practice
EMMA HEALEY, GILLIAN E. STILLFRIED, SIMON ECKERMANN, JAMES P. DAWBER, PHILIP R. CLINGAN and MARIE RANSON

Anticancer Research March 2013, 33 (3) 1053-1060;
You have access
Validation of a Simple Assay for the Quantification of the Capecitabine Metabolites 5’–DFCR and 5’–DFUR for Drug Monitoring in Patients Receiving Outpatient Chemotherapy
PHILIPP BUCHNER, EVA MIHOLA, AZRA SAHMANOVIC, TANJA STEININGER, CHRISTIAN DITTRICH and MARTIN CZEJKA

Anticancer Research March 2013, 33 (3) 881-886;
You have access
Phase II Trial of Erlotinib plus Capecitabine as First-line Treatment for Metastatic Pancreatic Cancer (XELTA Study)
RAFAEL LÓPEZ, CARLOS MÉNDEZ MÉNDEZ, MÓNICA JORGE FERNÁNDEZ, CARLOS ROMERO REINOSO, GUILLERMO QUINTERO ALDANA, MERCEDES SALGADO FERNÁNDEZ, JUAN DE LA CÁMARA GÓMEZ, MARGARITA REBOREDO LÓPEZ, MANUEL RAMOS VÁZQUEZ and SONIA CANDAMIO FOLGAR

Anticancer Research February 2013, 33 (2) 717-723;

Main menu